NCT02153918View on ClinicalTrials.gov

Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

July 28, 2017

Study Completion Date

January 16, 2018

Conditions
Prostate CancerProstatic NeoplasmsNeoplasms, Prostate
Interventions
BIOLOGICAL

PROSTVAC-V/TRICOM

A recombinant vaccinia virus vector vaccine containing the genes for human prostatic specific antigen (PSA) and three co-stimulatory molecules.

BIOLOGICAL

PROSTVAC-F/TRICOM

A recombinant fowlpox virus vector vaccine containing the genes for human PSA and three co-stimulatory molecules.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT02153918 - Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy | Biotech Hunter | Biotech Hunter